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ABSTRACT
Background and Objectives: As the number of bariatric
operations performed increases, the number of patients
requiring reoperation for failed weight loss is expected to
proportionately increase. Natural orifice surgery is an al-
ternative approach to revisional gastric bypass surgery
when postoperative complications, such as dilatation of
the gastrojejunostomy, gastrogastric fistula, and gastric
pouch, dilation occur.
Methods: The present article reports on the safe and
successful use of an endoscopic tissue plicating device in
a patient found to have a dilated gastric pouch and a
gastrogastric fistula 12 years after an open, nondivided
RYGB.
Results: The procedure was performed without compli-
cations and resulted in a reduced pouch size to approxi-
mately 30cc to 50cc and redirection of the flow of gastric
contents through her gastrojejunostomy. The patient’s
early satiety returned and, 1 year postoperatively, she had
incurred a 45-pound weight loss.
Discussion: The morbidity and mortality of revision gas-
tric bypass was avoided while the patient’s goal of mod-
erate weight loss was achieved. Tissue plicating devices
offer an alternative for repair of some postbariatric com-
plications. With the rapid advances in endoluminal tech-
nology and increasing experience with natural orifice sur-
gery, the ability to successfully address surgical problems
through less invasive means will continue to improve.
Key Words: Bariatric surgery, Complications, Fistula, En-
doscopy.
INTRODUCTION
Obesity is becoming an increasingly widespread epidemic
in the United States. According to a study performed
between 1999 and 2004,1 the incidence of overweight
children and adolescents has increased from 13.9% in
1999 to 2000 to 17.1% in 2003 to 2004. Similarly, obesity in
adults has increased from 30.5% to 32.2% during the same
time period. As a result, the number of weight loss sur-
geries being performed in the United States has predict-
ably increased from 13 365 in 1998 to more than 100 000
in 2003. This upward trend in bariatric surgery is likely to
continue until the obesity epidemic is controlled. With
this, bariatric surgeons are now encountering the chal-
lenge of more and more patients who require revisional
procedures secondary to failed weight loss or complica-
tions.
Single institution case series2 indicate that revisions are
performed in 5% to 60% of patients who have undergone
primary restrictive or restrictive-malabsorptive proce-
dures. Approximately 10% to 40% of patients fail to
achieve long-term weight loss after Roux-en-Y gastric by-
pass (RYBG), usually secondary to dilation of the gastric
pouch, and less commonly to gastrogastric (GG) fistula.3
Both open and laparoscopic surgical revision procedures
have been used for repair. However, surgical interven-
tion can be challenging and fraught with serious mor-
bidities, even in the most experienced hands. Second-
ary to factors like extensive intraabdominal adhesions,
ulcers, inflammation, bowel obstructions, and meta-
bolic disturbances leading to poor nutrition, revisional
surgery can lead to undesirable outcomes. These in-
clude leak, obstruction, perforation, staple-line disrup-
tion, blind loop syndrome, bleeding, stricture, sepsis,
wound dehiscence, pulmonary embolism, and death.4
Natural orifice surgery using the StomaphyX endoplica-
tor is an alternative approach to revisional gastric by-
pass surgery when postoperative complications occur.
Its minimally invasive nature makes it a safe and prom-
ising approach that may be associated with fewer intra-
operative and postoperative complications. The follow-
ing case highlights the use of StomaphyX to restore
weight loss in a patient after nondivided RYGB.
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CASE REPORTCASE REPORT
A 45-year-old white female presented 12 years after an
open, nondivided RYGB. Over the preceding 6 months,
she no longer experienced early satiety and gained 40
pounds. An upper GI (UGI) revealed a dilated gastric
pouch and a GG fistula, which was confirmed on endos-
copy. The pouch was estimated to be 150cc to 200cc with
a 2-cm GG fistula. The gastrojejunal (GJ) stoma was also
dilated.
The patient elected to proceed with natural orifice surgery
using the StomaphyX device. The device did not allow
placement of plications directly at the fistula site, but did
allow placement of full-thickness fasteners in a concentric
fashion from the GJ to the gastroesophageal junction.
Pouch size was reduced to approximately 30cc to 50cc.
Although postoperative UGI showed persistent GG fistula,
it also showed delayed flow through the GJ and a marked
decrease in pouch size, which ultimately enabled the
patient to achieve her desired outcome of weight loss.
At 2 months after surgery, the patient had regained early
satiety and lost 25 pounds. Now, nearly 1 year after her
gastric pouch endoplication, she continues to experience
early satiety and has lost 45 pounds. We will continue to
follow this patient and record her progress, as more long-
term data are necessary to evaluate the true efficacy of this
procedure (Figure 1).
DISCUSSION
Although bariatric surgery can result in durable and sig-
nificant weight loss, throughout its approximate 50-year
history, it has also been laden with failed operations and
serious postoperative complications that require revision.
Because of the significantly higher perioperative compli-
cation rate, the risk of revisional surgery must be balanced
against its potential benefit. The risk of developing peri-
operative complications after revisional bariatric surgery is
2 to 3 times greater, and the leak rate may be 5 to 10 times
higher. This is likely related to factors such as impaired
tissue quality and markedly decreased blood supply in
reoperative areas.5 Despite this, some authors advocate
operative revision for failed weight loss, because of even-
tual improvement in comorbidities associated with obe-
sity.6
One study reviewed a prospective database of patients
undergoing both primary and open revisional bariatric
procedures between 1998 and 2007. Of note, in this study
inadequate weight loss alone was not viewed as an indi-
cation for revision. A 9-fold increase in leaks, a 2- to 5-fold
increase in ICU utilization, and a 1.5-fold increase in
length of stay in patients undergoing revisional compared
with primary bariatric surgery was found. Despite this,
researchers had a 0% 30-day postoperative mortality rate
for revisions. They concluded that, in experienced hands
and via the open approach, revisional bariatric surgery
can be safe.2 Another case series reported on the out-
comes of 215 consecutive revisional bariatric operations
performed by 1 surgeon over the past 22 years. All but 3
of these procedures were performed open. Weight loss
failure was the indication for 151 of these, and complica-
tions from the primary procedure were the indication for
the other 64. Researchers found major perioperative com-
Figure 1. Endoscopy before (a) and after (b) plication using the StomaphyX.
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tions, 3 pulmonary embolisms, and 16 miscellaneous, in-
cluding 3 deaths (1.4%). Complications were more
frequent, occurring 36.9% of the time in patients who had
had primary procedures performed by other surgeons,
versus 10.3% of patients on whom the surgeon had per-
formed the initial procedure. This led him to suggest that
surgeons should perform their initial revisions on their
own patients, rather than patients being referred from
other surgeons.5
Because the number of operations performed for treating
morbid obesity has increased almost 10-fold during the
past decade, the number of patients requiring bariatric
revision for failed weight loss or complication has propor-
tionately increased also. While most of these are per-
formed open, some laparoscopic revisions performed on
primary laparoscopic operations, show fewer wound
complications, less blood loss, and lower mortality.6
With the advent of natural orifice surgery, the armamen-
tarium of possibilities to treat patients with failed primary
bariatric procedures has further broadened. Those most
likely to benefit from these procedures, in addition to the
morbidly obese, include the critically ill and those at high
risk for surgery because of significant comorbidities.7 A
case series of 3 patients with chronic gastric leaks after
RYGB showed successful leak closure using a variety of
endoscopic methods. These included argon plasma coag-
ulation, hemoclips, fibrin glue, Polyflex stent placement,
and distal GJ stenosis dilation. In all patients, leak closure
was achieved and symptoms resolved completely. The
only complication was stent migration in one patient, and
it was retrieved endoscopically.4 In addition, a retrospec-
tive analysis8 looked at treating 19 patients after various
bariatric procedures (11 with leaks, 2 with chronic fistulas,
and 6 with strictures) with endoscopic stent placement.
Oral feeding was started immediately in 79% of patients.
At mean follow-up of 3.6 months, 90% had symptomatic
improvement and 84% had resolution of leak or stricture.
Healing occurred at a mean of 33 days for leak, 46 days for
fistula, and 7 days for stricture. Stent migration occurred in
58% of stents placed, with 3 requiring surgical removal.
Another case series9 of 8 patients with significant weight
regain and dilated GJ anastomosis after RYGB demon-
strated the effectiveness of endoscopically placed sutures
at the rim of the GJ anastomosis. When tightened, these
sutures created tissue plications that reduced the anasto-
motic size. At 4 months, 6 of the 8 patients had lost weight
(average of 10kg), and their BMIs went from an average of
40.5 to 37.7. All endoscopic pouch reductions were done
without significant complication.
Most recently, a review10of the initial US experience using
the StomaphyX device to decrease gastric pouch size in
patients undergoing RYBG concluded that endoluminal
revision using the StomaphyX may offer a safe and effec-
tive alternative to revisional bariatric surgery. The authors
used the StomaphyX to perform endoluminal reduction of
gastric pouches in 39 patients, over 90% of whom were
female with an average age of 47.8 years and an average
body mass index (BMI) of 39.8 kg/m
2. At 2 weeks post-
procedure, patients had lost an average of 3.8kg (7.4%
excess body weight loss, EBWL). At 6 months, the remain-
ing patients being followed (n14) had lost 8.7kg (17%
EBWL), and at 1 year, the 6 patients still being followed
had lost 10kg (19.5% of EWBL). As with our patient,
symptoms improved, and no major complications oc-
curred.
The above studies suggest that some postbariatric compli-
cations can be successfully addressed using endoscopic
methods. Although several endoscopic examinations
were required, surgery and its associated complications
were avoided. The procedures were tolerated well with
minimal complications.4
Our case report demonstrates that the StomaphyX is an-
other device that warrants consideration in patients failing
to achieve satisfactory weight loss after RYGB. With fur-
ther study, and more long-term data, the efficacy of this
procedure will be better elucidated. We have had diffi-
culty recruiting patients for StomaphyX endoluminal revi-
sion at our institution, because the procedure is not cov-
ered by insurance, and the majority of our patients are
Medicare or Medicaid insured. Despite this, we suggest
that all postbariatric surgery patients with nonlife-threat-
ening complications, such as dilated gastric pouch, dilated
GJ anastomosis, and GG fistula be considered for endo-
luminal repair using StomaphyX. Exclusion criteria for
endoluminal revision should include the presence of peri-
toneal signs or a free perforation and leak into the peri-
toneal space, both of which require emergent operative
repair.
The StomaphyX is a transoral device that places full-
thickness polypropylene SerosaFuse fasteners, creating
gastric plications. These fasteners are nonabsorbable and
have strength equivalent to a 3-0 suture. Through tension-
free tissue approximation, they can be used to shrink
stoma and gastric pouch sizes. There have been several
case studies in which the device was successfully used for
pouch and anastomosis volume reduction. A case report
of 2 patients has also shown StomaphyX to be effective in
treating gastric leaks after RYGB.3 We attempted to ad-
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(Figure 2).
One potential drawback of the device is that its overall
structure and tip length somewhat limit the operator’s
ability to manipulate it. As a result, we were unable to
place fasteners in the location necessary to completely
close the gastrogastric fistula. However, the dilated gastric
pouch and GJ stoma were successfully reduced. As a
result, the restrictive portion of the patient’s initial proce-
dure was recreated. Her early satiety returned and she
began, and continues, to lose weight. In addition, the
procedure was fast (lasting approximately one hour), well
tolerated, and without complication. The patient went
home the following morning after tolerating a clear liquid
diet, which was advanced to a regular diet within the next
couple of days. The morbidity and mortality of revision
gastric bypass was avoided while the patient’s goal of
moderate weight loss was achieved (Figure 3).
CONCLUSION
The StomaphyX is an alternative for repair of some post-
bariatric complications. In this case, although the gastro-
gastric fistula remained patent, both the pouch size and GJ
stoma were reduced, allowing the patient to again expe-
rience early satiety. She, therefore, continues to lose
weight by restrictive means. With the rapid advances of
endoluminal technology and increasing experience with
Figure 2. (a) Tissue is drawn into the chamber, and (b) plications are created when the fasteners are deployed.
Figure 3. StomaphyX (a) Device and (b) tip.
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surgical problems through less-invasive means will con-
tinue to improve.11 Future research must focus not only on
the technological development of these devices, but also
on their long-term safety, efficacy, and durability, com-
pared with surgical alternatives, as they are applied in the
clinical setting.
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